Center for Research in Anabolic Skeletal Targets in Health and Illness

Lucknow, India

Center for Research in Anabolic Skeletal Targets in Health and Illness

Lucknow, India
SEARCH FILTERS
Time filter
Source Type

Kureel J.,Center for Research in Anabolic Skeletal Targets in Health and Illness | Dixit M.,Center for Research in Anabolic Skeletal Targets in Health and Illness | Tyagi A.M.,Center for Research in Anabolic Skeletal Targets in Health and Illness | Mansoori M.N.,Center for Research in Anabolic Skeletal Targets in Health and Illness | And 6 more authors.
Cell Death and Disease | Year: 2014

MicroRNAs (miRNAs) are short non-coding RNAs that interfere with translation of specific target mRNAs and thereby regulate diverse biological processes. Recent studies have suggested that miRNAs might have a role in osteoblast differentiation and bone formation. Here, we show that miR-542-3p, a well-characterized tumor suppressor whose downregulation is tightly associated with tumor progression via C-src-related oncogenic pathways, inhibits osteoblast proliferation and differentiation. miRNA array profiling in Medicarpin (a pterocarpan with proven bone-forming effects) induced mice calvarial osteoblast cells and further validation by quantitative real-time PCR revealed that miR-542-3p was downregulated during osteoblast differentiation. Over-expression of miR-542-3p inhibited osteoblast differentiation, whereas inhibition of miR-542-3p function by anti-miR-542-3p promoted expression of osteoblast-specific genes, alkaline phosphatase activity and matrix mineralization. Target prediction analysis tools and experimental validation by luciferase 3' UTR reporter assay identified BMP-7 (bone morphogenetic protein 7) as a direct target of miR-542-3p. It was seen that over-expression of miR-542-3p leads to repression of BMP-7 and inhibition of BMP-7/PI3K- survivin signaling. This strongly suggests that miR-542-3p suppresses osteogenic differentiation and promotes osteoblast apoptosis by repressing BMP-7 and its downstream signaling. Furthermore, silencing of miR-542-3p led to increased bone formation, bone strength and improved trabecular microarchitecture in sham and ovariectomized (Ovx) mice. Although miR-542-3p is known to be a tumor repressor, we have identified second complementary function of miR-542-3p where it inhibits BMP-7-mediated osteogenesis. Our findings suggest that pharmacological inhibition of miR-542-3p by anti-miR-542-3p could represent a therapeutic strategy for enhancing bone formation in vivo. © 2014 Macmillan Publishers Limited.

Loading Center for Research in Anabolic Skeletal Targets in Health and Illness collaborators
Loading Center for Research in Anabolic Skeletal Targets in Health and Illness collaborators